Cargando…
Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPARγ to Regulate Cholesterol Efflux and Endothelial Cell Inflammation
At present, due to the limitations of drug therapy targets for atherosclerosis, some patients fail to achieve satisfactory efficacy. Cholesterol efflux dysfunction and endothelial cell inflammation are considered to be important factors in the development of atherosclerosis. Peroxisome proliferator-...
Autores principales: | Wang, Mengxi, Xiang, Qian, Sun, Weixin, Zhang, Haowen, Shi, Ruijie, Guo, Jun, Tong, Huaqin, Fan, Manlu, Ding, Yuhan, Shi, Haibo, Yu, Peng, Shen, Le, Wang, Qiong, Chen, Xiaohu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744610/ https://www.ncbi.nlm.nih.gov/pubmed/36518993 http://dx.doi.org/10.1155/2022/2226168 |
Ejemplares similares
-
Qihuang needle therapy in senile cervical spondylotic radiculopathy
por: Yang, Juan, et al.
Publicado: (2023) -
Cholesterol efflux pathways, inflammation, and atherosclerosis
por: Groenen, Anouk G., et al.
Publicado: (2021) -
Qili Qiangxin Capsule Combined With Sacubitril/Valsartan for HFrEF: A Systematic Review and Meta-Analysis
por: Xiang, Qian, et al.
Publicado: (2022) -
Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy
por: Cao, Xu, et al.
Publicado: (2022) -
Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
por: Yuan, Jinxia, et al.
Publicado: (2022)